NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Efficacy of L-menthol on Breathlessness in Asthma
Efficacy of L-menthol on Breathlessness in Asthma

NCT07500974

RecruitingPhase 2

Sponsor: Region Skane

Conditions: Asthma

Interventions: L-menthol, Placebo

Countries: Sweden

The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Asthma.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* the subject has given written consent to participate in the study
* physician diagnosis of Asthma according to international guidelines
* mMRC (modified Medical Research Council) score of 1 or above
* age 18 years or older
* able to cycle
* able to understand and talk Swedish to participate in the study procedures, as judged by the Investigators.

Exclusion Criteria:

* resting peripheral oxygen saturation (SpO2) \< 92%
* hospitalization or clinical instability during the last four weeks
* treatment with supplementary oxygen at rest or during exercise
* contraindication to exercise testing in accordance with clinical practice guidelines
* expected survival shorter than six months as judged by the Investigator
* medical conditions including congestive heart failure, acute coronary artery disease, neuromuscular diseases, severe psychiatric illness, and olfaction disorder.
Locations (2)
  • Karlskrona, Blekinge County, Sweden
  • Lund, Sweden